Atrial septal defect

Transthoracic closure of atrial septal defect and ventricular septal defect without cardiopulmonary bypass

L. Wan, Yu, B. - T., Wu, Q. - C., Zeng, L., Wang, Q., Tang, J., Xu, Q. - R., Xu, H., Wang, W. - J., Cao, Y. - P., and Liu, J. - C., Transthoracic closure of atrial septal defect and ventricular septal defect without cardiopulmonary bypass, vol. 14, pp. 3760-3766, 2015.

The minimally invasive surgical transthoracic occlusion of an atrial septal defect (ASD) or a ventricular septal defect (VSD) is an increasingly widespread alternative treatment for congenital heart disease. The aim of this study is to summarize our clinical experience with minimally invasive surgical transthoracic occlusion of ASD and VSD without cardiopulmonary bypass (CPB). Between April 2011 and October 2012, 27 patients with ASD and 95 patients with VSD (78 men and 44 women) were considered for minimally invasive surgical transthoracic occlusion without CPB.

Subscribe to Atrial septal defect